These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3293273)

  • 21. Prolonged survival without posttransplant immunosuppression in a large animal model.
    Granger DK; Matas AJ; Jenkins MK; Moss AA; Chen SC; Almond PS
    Surgery; 1994 Aug; 116(2):236-41. PubMed ID: 8047990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to class I major histocompatibility complex antigens in chicken B cell chimeras. Effect of B cell depletion on transferability of tolerance.
    Lehtonen L; Vainio O; Veromaa T; Toivanen P
    Eur J Immunol; 1989 Mar; 19(3):425-31. PubMed ID: 2523310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cyclosporine on the induction of donor class I and class II MHC antigens in heart and kidney allografts in the rat.
    Milton AD; Spencer SC; Fabre JW
    Transplantation; 1986 Oct; 42(4):337-47. PubMed ID: 3532449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat.
    Hiller WF; Steiniger B; Klempnauer J
    Diabetes; 1993 Jan; 42(1):90-7. PubMed ID: 8420822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens.
    Armstrong HE; Bolton EM; McMillan I; Spencer SC; Bradley JA
    J Exp Med; 1987 Mar; 165(3):891-907. PubMed ID: 3546583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor class I and class II major histocompatibility complex antigen expression following liver allografting in rejecting and nonrejecting rat strain combinations.
    Settaf A; Milton AD; Spencer SC; Houssin D; Fabre JW
    Transplantation; 1988 Jul; 46(1):32-40. PubMed ID: 2969154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1396-402. PubMed ID: 8516825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definition, genetics, and possible significance of a newly defined endothelial antigen in the rat.
    Paul LC; Busch GJ; Paradysz JM; Carpenter CB
    Transplantation; 1983 Nov; 36(5):533-9. PubMed ID: 6356517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic aspects of the blood transfusion effect.
    Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1988 Sep; 46(3):438-43. PubMed ID: 3047933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A composite graft of islet plus donor lymph node cells induced donor specific tolerance in a "low responder" rat combination with class I MHC disparity.
    Maeda A; Ito T; Yumiba T; Ohkawa A; Uchikoshi F; Tori M; Sawai T; Nozawa M; Matsuda H
    Transplant Proc; 1999; 31(1-2):749-50. PubMed ID: 10083320
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: evidence for activation of resting B cells in vivo.
    Niimi M; Roelen DL; Wong W; Hara M; Morris PJ; Wood KJ
    Transplantation; 1997 Nov; 64(9):1330-5. PubMed ID: 9371676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of major-histocompatibility-complex-compatible and incompatible Langerhans cells on the survival of H-Y-incompatible skin grafts in rats.
    Chen HD; Raab S; Silvers WK
    Transplantation; 1985 Aug; 40(2):194-7. PubMed ID: 3895628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.